Looking Forward to Another ASH-TRAVAGANZA

It’s time again for hematology’s biggest event! This years 64th annual American Society of Hemotoloy (ASH) Meeting is being held in New Orleans, December 10-13.
In 2019, before most of us had even heard of COVID-19, ASH was held in Orlando, Florida with a whopping in-person attendance of over 30,000.
In 2020, like many other organizations, ASH’s Annual Meeting was fully virtual. For the 2021 event, the registration price for face to face and digital was the same, and the event produced equivalent content for both audiences. Programs ran simultaneously for online and in-person audiences with livestreamed content. With the combined in-person and digital audience, ASH reached its pre-pandemic attendance level of 30,000, with only 13,000 in-person attendees.
ASH officials say the approach for the 2022 ASH Annual Meeting is to create “two distinct offerings and two loyal audiences.” The goal is to bring the in-person component to 23,000 while also growing the digital audience, for a total of more than 35,000.
Whichever way you slice it, that’s huge! Of course ASH deals with every kind of blood related disease, and AML is only one of them. But when attending ASH you can hardly help but feel that our disease is the star of the show. There’s just so much happening.
First of all, there’s a whole additional day of Satellite Symposia. For AML patients, ASH really begins on Friday the 9th when we listen to programs like:
- A Thread To Pull: Unraveling The Complexities Of Myeloid Malignancies
- Acute Myeloid Leukemia: Reviewing Current Best Practice and Exploring Novel Paradigms Ahead
- Maintaining "Intensity" For Better Outcomes in AML: Guidance On Modern, Intensive Upfront Platforms in Challenging Patient Populations
- Experts Under the Microscope: Evaluating the Role Of Maintenance Therapy in Long-term Management of AML
But the real magic begins on Saturday with the presentation of abstracts, posters and papers.
Don’t take my word for it. Check it out here
Much will be written about ASH in the next few weeks. I’ll be hanging on every word. ASH! It never disappoints. Get ready to be blown away.
It’s time again for hematology’s biggest event! This years 64th annual American Society of Hemotoloy (ASH) Meeting is being held in New Orleans, December 10-13.
In 2019, before most of us had even heard of COVID-19, ASH was held in Orlando, Florida with a whopping in-person attendance of over 30,000.
In 2020, like many other organizations, ASH’s Annual Meeting was fully virtual. For the 2021 event, the registration price for face to face and digital was the same, and the event produced equivalent content for both audiences. Programs ran simultaneously for online and in-person audiences with livestreamed content. With the combined in-person and digital audience, ASH reached its pre-pandemic attendance level of 30,000, with only 13,000 in-person attendees.
ASH officials say the approach for the 2022 ASH Annual Meeting is to create “two distinct offerings and two loyal audiences.” The goal is to bring the in-person component to 23,000 while also growing the digital audience, for a total of more than 35,000.
Whichever way you slice it, that’s huge! Of course ASH deals with every kind of blood related disease, and AML is only one of them. But when attending ASH you can hardly help but feel that our disease is the star of the show. There’s just so much happening.
First of all, there’s a whole additional day of Satellite Symposia. For AML patients, ASH really begins on Friday the 9th when we listen to programs like:
- A Thread To Pull: Unraveling The Complexities Of Myeloid Malignancies
- Acute Myeloid Leukemia: Reviewing Current Best Practice and Exploring Novel Paradigms Ahead
- Maintaining "Intensity" For Better Outcomes in AML: Guidance On Modern, Intensive Upfront Platforms in Challenging Patient Populations
- Experts Under the Microscope: Evaluating the Role Of Maintenance Therapy in Long-term Management of AML
But the real magic begins on Saturday with the presentation of abstracts, posters and papers.
Don’t take my word for it. Check it out here
Much will be written about ASH in the next few weeks. I’ll be hanging on every word. ASH! It never disappoints. Get ready to be blown away.

about the author
Katie Braswell
Katie joined HealthTree as the Community Director for AML in 2021 and became HealthTree's Director of Education in 2023. Katie is a registered dietitian who is passionate about health literacy and patient empowerment. She loves to cook, travel and spend time with her newborn son, husband and dog.
More on Treatment Advances
Trending Articles


Get the Latest Acute Myeloid Leukemia Updates, Delivered to You.
By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.